Chargement en cours...
Blockade of HVEM for Prostate Cancer Immunotherapy in Humanized Mice
SIMPLE SUMMARY: Current immune checkpoint inhibitors have shown limitations for immunotherapy of prostate cancer. Thus, it is crucial to investigate other immune checkpoints to prevent disease progression in patients with prostate cancer. Here, we first show that the HVEM/BTLA immune checkpoint is a...
Enregistré dans:
| Publié dans: | Cancers (Basel) |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8235544/ https://ncbi.nlm.nih.gov/pubmed/34208480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13123009 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|